Novartis to buy breast cancer drug candidate in up to $3bn deal
  • Mar 21, 2026

Novartis to buy breast cancer drug candidate in up to $3bn deal

  • Reuters
Diabetes patients who stop GLP-1 drugs increase their heart risks
  • Mar 21, 2026

Diabetes patients who stop GLP-1 drugs increase their heart risks

  • Reuters
Cardiovascular risk increases when GLP-1 drug treatment stopped: study
  •  —
  • Mar 21, 2026

Cardiovascular risk increases when GLP-1 drug treatment stopped: study

  • Human Resources Director
How TrumpRx Drug Prices Compare With Those in Other Countries
  • Mar 20, 2026

How TrumpRx Drug Prices Compare With Those in Other Countries

  • The New York Times
Could GLP-1 drugs help your mental health? New study finds a link
  • Mar 20, 2026

Could GLP-1 drugs help your mental health? New study finds a link

  • Global News
Molecule in python blood could pave way for new obesity drugs, scientists say
  • Mar 19, 2026

Molecule in python blood could pave way for new obesity drugs, scientists say

  • The Guardian
TrumpRX lists many drugs' prices higher than what's paid in the UK
  • Mar 19, 2026

TrumpRX lists many drugs' prices higher than what's paid in the UK

  • Reuters
Federal government strikes task force of industry reps from pharma, biotech seeking to improve Canada’s competitiveness in the sector
  • Mar 18, 2026

Federal government strikes task force of industry reps from pharma, biotech seeking to improve Canada’s competitiveness in the sector

  • Government of Canada
Federal government announces $20 million in research and development funding for genomics
  •  —
  • Mar 18, 2026

Federal government announces $20 million in research and development funding for genomics

  • Calgary Herald
Ozempic, Wegovy: India's cheap weight-loss drugs could reshape global obesity fight
  • Mar 18, 2026

Ozempic, Wegovy: India's cheap weight-loss drugs could reshape global obesity fight

  • BBC News
  •  —
  • Mar 17, 2026

When generic versions of weight-loss drugs arrive, public plans should cover them, experts say

  • The Globe and Mail
Middle East war disrupts pharma air routes, risks cancer drugs supply
  • Mar 16, 2026

Middle East war disrupts pharma air routes, risks cancer drugs supply

  • Reuters
Geopolitical tensions show need for more made-in-Canada medicines, pharma stakeholders tell House Health Committee
  •  —
  • Mar 16, 2026

Geopolitical tensions show need for more made-in-Canada medicines, pharma stakeholders tell House Health Committee

  • The Hill Times
Ontario restricts new rental building in favour of Sanofi pharma plant
  •  —
  • Mar 14, 2026

Ontario restricts new rental building in favour of Sanofi pharma plant

  • The Globe and Mail
Major changes to cardiovascular guidelines suggest taking statins as young as 30
  • Mar 14, 2026

Major changes to cardiovascular guidelines suggest taking statins as young as 30

  • STAT
FDA approves use of RSV vaccine in at-risk younger adults
  • Mar 14, 2026

FDA approves use of RSV vaccine in at-risk younger adults

  • CIDRAP
Xenon stock soars as B.C. drug developer reports strong results for epilepsy treatment
  •  —
  • Mar 13, 2026

Xenon stock soars as B.C. drug developer reports strong results for epilepsy treatment

  • The Globe and Mail
Wegovy users have five times greater risk of sudden sight loss than Ozempic users, study finds
  • Mar 11, 2026

Wegovy users have five times greater risk of sudden sight loss than Ozempic users, study finds

  • The Guardian
Ottawa should prioritize reviews and procurement of Canadian-made drugs, manufacturers say
  •  —
  • Mar 11, 2026

Ottawa should prioritize reviews and procurement of Canadian-made drugs, manufacturers say

  • The Globe and Mail
FDA warns Novo Nordisk of potential unreported GLP-1 side effects
  • Mar 11, 2026

FDA warns Novo Nordisk of potential unreported GLP-1 side effects

  • NBC News
U.S. FDA says it met with states interested in importing cheaper drugs from Canada
  •  —
  • Mar 10, 2026

U.S. FDA says it met with states interested in importing cheaper drugs from Canada

  • The Globe and Mail
Trump admin looks to boost biosimilars to lower drug costs
  •  —
  • Mar 10, 2026

Trump admin looks to boost biosimilars to lower drug costs

  • Axios
Can a "Living Drug" Cure Autoimmune Diseases?
  •  —
  • Mar 09, 2026

Can a "Living Drug" Cure Autoimmune Diseases?

  • The New Yorker
Regina researchers seek new antibiotic treatments that could save lives
  •  —
  • Mar 09, 2026

Regina researchers seek new antibiotic treatments that could save lives

  • Regina Leader-Post
Hims & Hers Health and Novo Nordisk end lawsuit over weight loss medications, enter collaboration
  • Mar 09, 2026

Hims & Hers Health and Novo Nordisk end lawsuit over weight loss medications, enter collaboration

  • Associated Press
Anti-obesity treatment could cost as little as $3 per month
  • Mar 09, 2026

Anti-obesity treatment could cost as little as $3 per month

  • Canadian Affairs
Canada-U.S. Trade Minister and federal Health Minister meet with pharma sector as Trump doubles down on cutting U.S. drug prices
  •  —
  • Mar 08, 2026

Canada-U.S. Trade Minister and federal Health Minister meet with pharma sector as Trump doubles down on cutting U.S. drug prices

  • The Hill Times
  • Mar 07, 2026

Canada and CSL Seqirus, a Global Leader in Influenza Vaccines, agree on new Pandemic Preparedness Contract

  • CISION
Weight-loss jab could be made for $3 a month, study finds
  • Mar 06, 2026

Weight-loss jab could be made for $3 a month, study finds

  • The Guardian
U.S. FDA approves J&J's blood cancer drug after speedy review
  • Mar 06, 2026

U.S. FDA approves J&J's blood cancer drug after speedy review

  • Reuters
Vaccine for Bacterial Diarrhea Successful in Human Trials
  • Mar 06, 2026

Vaccine for Bacterial Diarrhea Successful in Human Trials
China approves pfizer's glp-1 drug for weight management
  • Mar 06, 2026

China approves pfizer's glp-1 drug for weight management

  • Reuters
Fragile X diagnosis propelled our family into advocacy and drug discovery
  • Mar 05, 2026

Fragile X diagnosis propelled our family into advocacy and drug discovery

  • Patient Voice
  •  — 
  • Nick Parr
Weight loss drugs may stop people getting addicted to drugs and alcohol, study finds
  • Mar 04, 2026

Weight loss drugs may stop people getting addicted to drugs and alcohol, study finds

  • The Guardian
Top FDA drug official is trying to hire a friend who's seeking to put pregnancy warnings on antidepressants
  • Mar 04, 2026

Top FDA drug official is trying to hire a friend who's seeking to put pregnancy warnings on antidepressants

  • Associated Press
Most Patients Keep Weight Off With Fewer GLP-1 Shots, Study Finds
  •  —
  • Mar 04, 2026

Most Patients Keep Weight Off With Fewer GLP-1 Shots, Study Finds

  • The New York Times
3 million Canadians use GLP-1 drugs. Survey says that's changing their appetites — and habits
  • Mar 04, 2026

3 million Canadians use GLP-1 drugs. Survey says that's changing their appetites — and habits

  • CBC News
RNA vaccine funding cuts threaten decades of scientific progress
  • Mar 04, 2026

RNA vaccine funding cuts threaten decades of scientific progress

  • CIDRAP
US FDA warns 30 telehealth firms over misleading ads for compounded weight‑loss drugs
  • Mar 03, 2026

US FDA warns 30 telehealth firms over misleading ads for compounded weight‑loss drugs

  • Reuters
3M Canadian adults taking GLP-1 drugs, reshaping eating and spending, survey suggests
  • Mar 03, 2026

3M Canadian adults taking GLP-1 drugs, reshaping eating and spending, survey suggests

  • CTV News
Health Canada approves Ozempic to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes
  • Mar 02, 2026

Health Canada approves Ozempic to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes

  • CISION
Researchers praise 'stunning' results of new prostate cancer treatment
  • Feb 28, 2026

Researchers praise 'stunning' results of new prostate cancer treatment

  • The Guardian

Get Canada’s essential briefing on health policy, science, and system change.  Get Briefing